IDH1 R132
Showing 1 - 25 of 3,114
Advanced Malignancies That Harbor IDHR132 Mutations Trial in Worldwide (IDH305)
Active, not recruiting
- Advanced Malignancies That Harbor IDHR132 Mutations
-
Boston, Massachusetts
- +12 more
Dec 9, 2021
AML, Adult Trial in Italy (IDH mutation test performed at diagnosis or relapse until January 31st, 2019.)
Completed
- AML, Adult
- IDH mutation test performed at diagnosis or relapse until January 31st, 2019.
-
Alessandria, Italy
- +23 more
Dec 31, 2021
Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)
Recruiting
- Recurrent IDH1/2 Mutated Glioma
-
Paris, FrancePitie Salpetriere Hospital
Aug 29, 2022
Non Invasive IDentification of Gliomas With IDH1 Mutation
Completed
- Non Invasive Diagnosis of Glioma
-
Paris, Sélectionner..., FranceGH Pitié-Salpêtrière, 47 Bd de l'Hopital,
Aug 25, 2021
Glioma Trial in Germany (IDH1 peptide vaccine)
Completed
- Glioma
- IDH1 peptide vaccine
-
Berlin, Germany
- +7 more
Nov 6, 2018
Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
Completed
- Glioma, Malignant
- Glioma, Mixed
-
Jilin, China
- +3 more
Nov 12, 2021
Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Recurrent Myeloproliferative Tumor Trial in Chicago
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- +4 more
- Cytarabine
- +4 more
-
Chicago, IllinoisNorthwestern University
Mar 26, 2021
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Gut microBIOME in Glioblastoma Patients Receiving
Not yet recruiting
- Glioblastoma, IDH-wildtype
- (no location specified)
Apr 5, 2022
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Canada, United States (Enasidenib, Enasidenib
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Enasidenib
- Enasidenib Mesylate
-
Birmingham, Alabama
- +17 more
Jun 21, 2021
Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)
Not yet recruiting
- Brain Tumor
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1
Not yet recruiting
- Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Ivosidenib 500mg
- Placebo
- (no location specified)
Nov 7, 2023
Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia (AML)
- +3 more
-
Birmingham, Alabama
- +26 more
Sep 12, 2022
Utility of Primary Glioblastoma Cell Lines
Recruiting
- Tumor
- Brain Tumor
-
Pozzilli, IS, ItalyNeuromed IRCCS
Apr 9, 2021
Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
-
Costa Mesa, California
- +49 more
Aug 24, 2022
Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)
Recruiting
- Glioblastoma Multiforme
- 11C-Methionine PET/CT
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Nov 3, 2022
Chronic Plaque Psoriasis Trial in Canada, United States (Topical roflumilast)
Enrolling by invitation
- Chronic Plaque Psoriasis
- Topical roflumilast
-
Beverly Hills, California
- +68 more
Nov 9, 2022
Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)
Not yet recruiting
- Low Grade Glioma of Brain
- PEPIDH1M vaccine + vorasidenib
-
Durham, North CarolinaDuke University Medical Center
Nov 2, 2022
Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)
Recruiting
- Atopic Dermatitis Eczema
- ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
-
Birmingham, Alabama
- +91 more
Jan 26, 2023
Acne Vulgaris Trial in Belgium, Canada, United States (IDP-126 Gel, IDP-126 Vehicle Gel, Epiduo® Forte Gel)
Active, not recruiting
- Acne Vulgaris
- IDP-126 Gel
- +2 more
-
Bryant, Arkansas
- +41 more
Jul 13, 2022